About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | COPD Clinical Trials in Houston | 164 Studies

Clinical Trials COPDHouston

COPD Clinical Trials in Houston

Find 164 clinical trials for copd near Houston, Texas. Connect with research centers in your area.

All COPD trials nationwide All trials in Houston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 41-60 of 164 trials

CompletedA Study To Investigate The Safety, Toleration And Efficacy of PF00610355 In Chronic Obstructive Pulmonary Disease (COPD) Patients.To assess the effects and safety of PF-00610355 on patients with chronic obstructive lung disease (COPD)NCT00808288·Fairhope, Alabama and 74 others

PreviousPage 3 of 9Next

COPD Trials in Other Cities

New York Los Angeles Chicago Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

RecruitingmyAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the HomeParallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care…NCT05204888·Birmingham, Alabama and 26 others

CompletedDetecting Errors In Using Metered Dose Inhalers (MDI) Among Asthma And Chronic Obstructive Pulmonary Disease (COPD) PatientsMetered Dose Inhaler (MDI) and Dry Powdered Inhaler (DPI) are the two most common devices used to deliver medicine in conditions such as asthma and chronic obstructive pulmonary…NCT02447575·Houston, Texas

RecruitingA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very…NCT06883305·Foley, Alabama and 304 others

CompletedStudy To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On A Background Of Tiotropium BromidePH-797804 is an oral anti-inflammatory drug that may reduce the inflammation that is associated with Chronic Obstructive Pulmonary Disease (COPD).NCT01543919·Birmingham, Alabama and 131 others

CompletedA Study of the Efficacy and Safety of EP-101 ( (SUN101) in Subjects With Moderate to Severe Chronic Obstructive Pulmonary DiseaseThis is a randomized, double-blind, placebo-controlled, parallel arm study.NCT01706536·Jasper, Alabama and 25 others

CompletedEvaluation of the Long- Term Effects of Spiriva on Lung Function in COPD PatientsThe primary objective of this trial is to determine whether daily treatment with tiotropium (Spiriva®, Bromuro de Tiotropio®) inhalation capsule via HandiHaler® reduces the rate…NCT00144339·Anniston, Alabama and 489 others

TerminatedTiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)The primary objectives of this study are to assess bronchodilator efficacy as determined by forced expiratory volume in one second (FEV1), the effect on dyspnoea as determined by…NCT00662740·Boulder, Colorado and 71 others

CompletedValidation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary DiseaseThe purpose of this study is to evaluate a new questionnaire to capture the patient experience of COPD.NCT00984659·Jasper, Alabama and 38 others

CompletedA Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)This is a Phase III randomized, double-blind, parallel group, multi-center, 52-week COPD exacerbation and lung function study with PT009 320/9.6 μg, PT009 160/9.6 μg and PT005 9.6…NCT02727660·Dothan, Alabama and 281 others

CompletedHigh Dose Trial in COPDThe primary objective of this study was to compare the efficacy and safety of 200 μg and 400 μg of BEA 2180 BR to tiotropium 5 μg and placebo when each was delivered by the…NCT00128440·Lakewood, California and 12 others

CompletedRoflumilast or Azithromycin to Prevent COPD Exacerbations TrialA multi-center, randomized, 72-month, parallel- group, non-inferiority, phase III study to compare the effectiveness of roflumilast (Daliresp, 500 mcg quaque die (QD) or alternate…NCT04069312·Birmingham, Alabama and 27 others

CompletedEvaluation of the Spiration® Valve System for Emphysema to Improve Lung FunctionEMPROVE is a multicenter, prospective, randomized, controlled study designed to evaluate the safety and long-term effectiveness of the Spiration Valve System in patients with…NCT01812447·Fort Smith, Arkansas and 33 others

CompletedEvaluation of Lung Function and Symptoms in Patients Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator MonotherapyA multicenter study to evaluate lung function and symptoms in subjects with COPD who have been on regular use of only one long-acting bronchodilator.NCT00791518·Birmingham, Alabama and 56 others

CompletedA 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPDThis is a phase III multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of GSK573719/GW642444 Inhalation Powder…NCT01313650·Tucson, Arizona and 164 others

CompletedDiagnosing Respiratory Disease in Children Using Cough Sounds 2The purpose of this prospective study is to evaluate the efficacy of the ResAppDx software application in the diagnosis of childhood acute respiratory disease, including…NCT03392363·Boston, Massachusetts and 2 others

CompletedEfficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary DiseaseThis study assessed the efficacy and safety of indacaterol (150 µg once daily \[od\]) when combined with tiotropium (18 µg od) versus tiotropium (18 µg od) treatment alone in…NCT00877383·Anniston, Alabama and 175 others

CompletedDose-range Finding Efficacy and Safety Study for QBW251 in COPD PatientsThis clinical study was designed to support the dose selection for future studies by evaluating efficacy and safety of different QBW251 doses in Chronic obstructive pulmonary…NCT04072887·Andalusia, Alabama and 147 others

CompletedStudy To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) Taking Salmeterol Xinafoate/Fluticasone Propionate CombinationPH-797804 is an oral ant-inflammatory drug that may reduce the inflammation that is associated with COPD.NCT01321463·Mobile, Alabama and 73 others

TerminatedA Study to Evaluate Biomarkers in Chronic Obstructive Pulmonary DiseaseThe primary objective of this study is to identify biomarkers that can be used for evaluation of efficacy in subjects presenting with AECOPDNCT01268072·Baltimore, Maryland and 9 others

Other Conditions in Houston

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia